Diagnosis and management of pheochromocytoma in an academic hospital 3 years after formation of a pheochromocytoma interest group

Endocrine Practice

Volumn 17, Issue 3, 2011, Pages 356-362

  Yu, Run ^a   Nissen, Nicholas N ^a   Dhall, Deepti ^a   Phillips, Edward ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL BIOPSY; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC SCREENING; HUMAN; MALE; MEDICAL RECORD; PHEOCHROMOCYTOMA; PREOPERATIVE PERIOD; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOCUS GROUPS; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PRACTICE GUIDELINES AS TOPIC; PUBLIC OPINION; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 79959653814     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10274.OR     Document Type: Article

References (23)

1. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med. 2009; 122:85-95.
2. Bravo EL, Tagle R. Pheochromocytoma: State-of-the-art and future prospects. Endocr Rev. 2003;24:539-553. (Pubitemid 37056243)
3. Manger WM. An overview of pheochromocytoma: History, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci. 2006;1073:1-20. (Pubitemid 44911993)
4. Yu R, Nissen NN, Dhall D, Wei M. Pheochromocytoma in patients suspected of harboring adrenal metastasis: Management and clinical predictors. Endocr Pract. 2008; 14:967-972.
5. Yu R, Furmark L, Wong C. Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract. 2009;15:10-16.
6. Yu R. Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma between 2000 and 2008. Endocr Pract. 2009;15:313-321.
7. Zalom ML, Waxman AD, Yu R, Lee J, Ih G, Wolin EM. Metabolic and receptor imaging in patients with neuroendocrine tumors: Comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium In 111 pentetreotide. Endocr Pract. 2009;15:521-527.
8. Lev I, Kelekar G, Waxman A, Yu R. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Endocr Pract. 2010;16:398-407.
9. Wong C, Yu R. Preoperative preparation for pheochromocytoma resection: Physician survey and clinical practice. Exp Clin Endocrinol Diabetes. 2010;118:400-404.
10. Yu R, Wei M. False positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes. 2010;118:577-585.
11. Yu R, Ginsberg E. Natural history of a sporadic pheochromocytoma. Endocr Pract. 2008;14:391.
12. Chang JI, Hong SS, Gastelum CJ, Nissen NN, Chu R, Yu R. Thoracic spinal cord compression by metastatic pheochromocytoma. Hosp Physician. 2009;45:35-40.
13. Buchbinder NA, Yu R, Rosenbloom BE, Sherman CT, Silberman AW. Left ventricular thrombus and embolic stroke caused by a functional paraganglioma. J Clin Hypertens (Greenwich). 2009;11:734-737.
14. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656-2666. (Pubitemid 36724439)
15. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience. J Clin Endocrinol Metab. 2003;88:4533-4539. (Pubitemid 37357488)
16. Munver R, Fromer DL, Watson RA, Sawczuk IS. Evaluation of the incidentally discovered adrenal mass. Curr Urol Rep. 2004;5:73-77.
17. Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601-610. (Pubitemid 46220820)
18. Pacak K, Eisenhofer G, Ahlman H, et al; International Symposium on Pheochromocytoma. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. 2007;3:92-102. (Pubitemid 46146962)
19. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069-4079.
20. Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: Current status and initiatives for future progress. Endocr Relat Cancer. 2004;11: 423-436. (Pubitemid 39331275)
21. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H. Clinical review: Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab. 2007;92:1217-1225. (Pubitemid 46556388)
22. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: Which test is best? JAMA. 2002;287:1427-1434. (Pubitemid 34250506)
23. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459-1466. (Pubitemid 34755714)